Literature DB >> 6297938

Embryonal carcinoma cell growth and differentiation. Production of and response to molecules with transforming growth factor activity.

A Rizzino, L S Orme, J E De Larco.   

Abstract

Transforming growth factors are known to induce anchorage-independent growth of non-transformed cells, and are released by a variety of cells, including MSV-transformed cells. This study demonstrates that the differentiated cells derived from F9 and PC-13 embryonal carcinoma cells, but not the parental cells themselves, respond by increased growth to several factors released by MSV-transformed cells, including partially purified sarcoma growth factor. The chemical properties of the growth-promoting activity are shown to match the chemical properties of the transforming growth factors released by MSV-transformed cells. Furthermore, F9 and PC-13 embryonal carcinoma cells, which do not respond to factors released by MSV-transformed cells, are shown to release factors with transforming growth factor activity. Based on the close relationship between mouse embryonal carcinoma cells and cells of early mouse embryos, it is suggested that molecules with transforming growth factor activity may play a role during the early stages of mammalian development.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6297938     DOI: 10.1016/0014-4827(83)90116-7

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  24 in total

1.  NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner.

Authors:  Cory T Bernadt; Tamara Nowling; Matthew S Wiebe; Angie Rizzino
Journal:  Gene Expr       Date:  2005

2.  Regulation of the Nanog gene by both positive and negative cis-regulatory elements in embryonal carcinoma cells and embryonic stem cells.

Authors:  Brian Boer; Jesse L Cox; David Claassen; Sunil Kumar Mallanna; Michelle Desler; Angie Rizzino
Journal:  Mol Reprod Dev       Date:  2009-02       Impact factor: 2.609

3.  High chemotactic response to platelet-derived growth factor of a teratocarcinoma differentiated mesodermal cell line.

Authors:  C Liapi; F Raynaud; W B Anderson; D Evain-Brion
Journal:  In Vitro Cell Dev Biol       Date:  1990-04

4.  Autocrine growth induced by the insulin-related factor in the insulin-independent teratoma cell line 1246-3A.

Authors:  Y Yamada; G Serrero
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

5.  Density-induced down regulation of epidermal growth factor receptors.

Authors:  A Rizzino; P Kazakoff; J Nebelsick
Journal:  In Vitro Cell Dev Biol       Date:  1990-05

6.  Growth requirements, growth factor responsiveness, and growth factor secretion of three human embryonal carcinoma cell lines.

Authors:  W Verbeek; C Bokemeyer; H Falk; H J Schmoll
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

7.  Early mouse embryos produce and release factors with transforming growth factor activity.

Authors:  A Rizzino
Journal:  In Vitro Cell Dev Biol       Date:  1985-09

8.  Endoderm-secreted factor stimulates growth of embryonal carcinoma stem cells.

Authors:  E L Germain; J W Littlefield
Journal:  In Vitro Cell Dev Biol       Date:  1986-02

9.  Effects of anti-EGF serum on newborn mice.

Authors:  W Zschiesche; K Eckert
Journal:  Experientia       Date:  1988-03-15

10.  Fibroblast growth factor complexed to the cytotoxin saporin is growth inhibitory but not cytotoxic for embryonal carcinoma cells.

Authors:  K Miller; P J Wilder; A Rizzino
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.